Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2007
12/27/2007US20070299131 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them
12/27/2007US20070299130 Benzopyran Compound
12/27/2007US20070299126 Substituted pyrrole-indoles
12/27/2007US20070299122 Method of Treating Pathological Blushing
12/27/2007US20070299120 1 -(Methylsulfonylamino)-3 - [2-(4-methoxyphenyl)ethyl]-4-(4-methoxyphenyl) -2-imidazolidinone; atrial-selective antiarrhythmic agents; cardiovascular disorders; arrhytmia, atrial fibrillation, atrial flutter, thromboembolism, stroke, and heart failure
12/27/2007US20070299119 Prophylactic or Therapeutic Agent for Severe Diabetic Retinopathy
12/27/2007US20070299116 Human protein tyrosine phosphatase inhibitors and methods of use
12/27/2007US20070299111 Benzamide derivatives and uses related thereto
12/27/2007US20070299107 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
12/27/2007US20070299105 2-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use
12/27/2007US20070299101 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
12/27/2007US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors
12/27/2007US20070299090 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes
12/27/2007US20070299088 Novel Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives
12/27/2007US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent
12/27/2007US20070299073 Imidazolyl derivatives
12/27/2007US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity
12/27/2007US20070299051 Tricyclic Guanidine Derivatives as Sodium-Proton Exchange Inhibitors
12/27/2007US20070299047 Combination of Organic Compounds
12/27/2007US20070299025 Method for Detecting the Risk of Cardiovascular Diseases Such as Acute Myocardial Infarction and Coronary Heart Disease By Analysing Defesin
12/27/2007US20070299017 Compositions for lowering blood serum cholesterol and use in foods, beverages, and health supplements
12/27/2007US20070299014 Casein hydrolyzate, process for producing the same and use thereof
12/27/2007US20070299012 Method of preventing progression of hypertension-induced heart failure with PKC peptides
12/27/2007US20070298996 penile erectile dysfunction; administering a coiled-coil domain of cartilage oligomeric matrix protein linked to a Tie2 receptor binding domain which is a fibrinogen-like domain of angiopoietin-1
12/27/2007US20070298136 Cholesterol regulating agent
12/27/2007US20070298124 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits
12/27/2007US20070298123 Anti-angiogenic compositions and methods of use
12/27/2007US20070298115 Nanoparticulate fibrate formulations
12/27/2007US20070298104 Cyanoisoquinoline compounds and methods of use thereof
12/27/2007US20070298049 Therapeutic Agent for Polycystic Ovary Syndrome (Pcos)
12/27/2007US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
12/27/2007US20070298031 Methods for preventing or treating neuromuscular or muscular conditions by peripherally administered erythropoietin
12/27/2007US20070298028 Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3)
12/27/2007US20070298021 Methods and Compositions for the Treatment or Prevention of Secondary Ischemic Injury
12/27/2007US20070298020 Apoptotic entities for use in treatment of endothelium dysfunction disorders
12/27/2007DE4240430B4 Stabilisiertes pharmazeutisches Mittel, enthaltend einen HMG-CoA-Reduktase-Inhibitor Wirkstoff A stabilized pharmaceutical composition comprising an HMG-CoA reductase inhibitor active agent
12/27/2007DE102006029573A1 Neue Quinazoline als Kinase-Inhibitoren New quinazolines as kinase inhibitors
12/27/2007DE102006029445A1 Neue 3-Cyano-chinoline als Kinase-Inhibitoren New 3-cyano-quinolines as kinase inhibitors
12/27/2007DE102006020327A1 Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung Heterocyclic-substituted, fused pyrazole derivatives and their use
12/27/2007CA2655728A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists
12/27/2007CA2655574A1 Imidazole kv1.5 potassium channel inhibitors
12/27/2007CA2655570A1 Dha esters and use thereof in treatment and prevention of cardiovascular disease
12/27/2007CA2655527A1 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
12/27/2007CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
12/27/2007CA2654354A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
12/27/2007CA2654262A1 Kv1.5 potassium channel inhibitors
12/27/2007CA2648993A1 Grafted polymers and uses thereof
12/26/2007EP1870473A1 Adeno-associated virus-mediated delivery of angiogenic factors
12/26/2007EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/26/2007EP1870103A2 Use of uridine in combination with choline for the treatment of memory disorders
12/26/2007EP1870098A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes
12/26/2007EP1870095A1 Composition for increasing anti-oxidation activity in blood
12/26/2007EP1869165A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
12/26/2007EP1869056A1 Novel 5-substituted 7-amino-ý1,3¨thiazoloý4,5-d¨pyrimidine derivatives
12/26/2007EP1869055A1 Novel 5,7-disubstituted ý1,3¨thiazoloý4,5-d¨pyrimidin-2(3h)-one derivatives
12/26/2007EP1869023A1 New tricyclic angiotensin ii agonists
12/26/2007EP1869009A1 New bicyclic angiotensin ii agonists
12/26/2007EP1868982A2 Compounds that stimulate glucose utilization and methods of use
12/26/2007EP1868626A1 Improved method for preparing ginkgo extracts having a reduced content of polycyclic aromatic hydrocarbons
12/26/2007EP1868598A2 A new dosing regimen for ion channel modulating compounds for treating acute atrial fibrillation in a human
12/26/2007EP1868568A1 Method for preparing a ginkgo extract having a reduced content of 4'-o-methyl pyridoxine and/or biflavones
12/26/2007EP1868454A2 A method and composition for nutritionally improving glucose control and insulin action
12/26/2007EP1525193B1 Acylaminothiazole derivatives, preparation and therapeutic use thereof
12/26/2007EP1265914B1 Wnt-1 related polypeptides, and nucleic acids encoding the same
12/26/2007EP1233769B1 Imidazole derivatives
12/26/2007CN101094851A Novel compound having lipase inhibitory activity
12/26/2007CN101094678A Blood cholesterol reducing oral composition
12/26/2007CN101094671A Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor
12/26/2007CN101094667A Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
12/26/2007CN101092621A Uncoupling protein gene of lamprey and application
12/26/2007CN101092432A Superoxide dismutase mimics for the treatment of ocular disorders and diseases
12/26/2007CN101092413A Hydrate of medicinal salt of Fasudil
12/26/2007CN101092409A C-aryl glucoside sglt2 inhibitors and method
12/26/2007CN101092405A Derivative of new benzothiadiazines, preparation method and usage
12/26/2007CN101091793A New usage of anti alcoholic drug containing acetadehyde dehydrogenase
12/26/2007CN101091782A Pearl pill, and preparation method
12/26/2007CN101091751A Composition of Chinese traditional medicine for treating high blood pressure, and preparation method
12/26/2007CN101091747A Preparation method of forsythia fruit and effective part, and new message
12/26/2007CN101091744A Method for extracting effective part of Chinese traditional medicine of red sage root and rhizome of Sichuan lovage
12/26/2007CN101091743A Extractive of red sage root of Chinese traditional medicine, and preparation method
12/26/2007CN101091738A Composition of medicine in use for treating cardiovascular disease and cerebrovascular disease, and preparation method
12/26/2007CN101091728A New application of total flavone of phoenix-tail fern
12/26/2007CN101091715A Composition of medication for treating cardiovascular diseases and cerebrovascular diseases
12/26/2007CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease
12/26/2007CN100357433C eNOS mutations useful for gene therapy and therapeutic screening
12/26/2007CN100357325C Preparation method of anti apoA1, apoB antibody and reagent box used for detecting apoAI, apoB
12/26/2007CN100357306C Rosemary acid anhydride compound ,its preparation method and use for treatment and prevention of AIDS
12/26/2007CN100357281C Bicyclic compounds, process for their preparation and pharmaceutical composition containing them
12/26/2007CN100357279C Process for the manufacture of valsartan
12/26/2007CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors
12/26/2007CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
12/26/2007CN100357270C D-proline derivative
12/26/2007CN100357244C Aspirin-triggered lipid mediators
12/26/2007CN100357008C Apparatus and method for manufacturing tabasheer
12/26/2007CN100356979C Integrin expression inhibitors
12/26/2007CN100356932C Use of astragalus root in preparing medicine for dilating blood vessel
12/26/2007CN100356924C Phenoduopan methanesulphonate medicinal composition and its preparation
12/26/2007CN100356917C Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes
12/26/2007CN100356914C Method for preparing soybean isoflavone tablet
12/26/2007CN100356913C R-bambuterol, its preparation and therapeutic uses
1 ... 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 ... 1595